DocGo DCGO Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value at other companies

Viemed Healthcare, Inc.VMD

——

SRT

Strata Critical Medical, Inc. Class A Common StockSRTA

——

Other financials

Income statement

See full

Revenue$75.6M-21.3%

Gross profit-$407.9M-25.6%

Operating income-$18.7M-33.7%

Net income-$14.8M-57.0%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$46.8M-54.6%

Total debt$28.5M-7.6%

Total equity$132.3M-57.2%

Total assets$209.2M-51.4%

Cash flow

See full

Operating cash flow-$4.7M-151%

CapEx$430.3K-58.2%

Free cash flow-$5.1M-162%

Valuation

See full

Market cap$50.98M-67.2%

Enterprise value$32.67M-59.1%

P/S0.2×-0.2×

Profitability

See full

Operating margin-60.6%—

Net margin-62.2%—

FCF margin14.6%+8.1pp

Returns & leverage

See full

Return on equity-85%—

Debt / equity0.2×+0.1×

Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is DocGo's share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value?: DocGo (DCGO) reported share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value of $0 in Q1 2026.
How has DocGo's share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value changed year-over-year?: DocGo's share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value decreased by 100.0% year-over-year, from $830.31K to $0.